- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies ; volume:35 ; number:3 ; day:1 ; month:3 ; year:2018 ; pages:289-310 ; date:3.2018
Advances in therapy ; 35, Heft 3 (1.3.2018), 289-310, 3.2018
- Creator
-
Rodiño-Janeiro, Bruno K.
- Contributor
-
Vicario, María
Alonso-Cotoner, Carmen
Pascua-García, Roberto
Santos, Javier
SpringerLink (Online service)
- DOI
-
10.1007/s12325-018-0673-5
- URN
-
urn:nbn:de:1111-2018052015691
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rodiño-Janeiro, Bruno K.
- Vicario, María
- Alonso-Cotoner, Carmen
- Pascua-García, Roberto
- Santos, Javier
- SpringerLink (Online service)
Other Objects (12)
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
Diet in irritable bowel syndrome
Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines
Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions
Clinical implications of irritable bowel syndrome
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
Diet in irritable bowel syndrome
Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines
Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions
Clinical implications of irritable bowel syndrome
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
Diet in irritable bowel syndrome
Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines
Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions
Clinical implications of irritable bowel syndrome